Pharmaceutical Contract Development And Manufacturing Organization Cdmo
Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Forecasts to 2030 - Global Analysis By Service Type (Development Services, Manufacturing Services, Clinical Trial Material (CTM) Production, Scale-Up Services, Regulatory Support Services and Other Service Types), Molecule Type, Dosage Form, Application, End User and By Geography
According to Stratistics MRC, the Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market is accounted for $243.29 billion in 2024 and is expected to reach $354.68 billion by 2030 growing at a CAGR of 8.4% during the forecast period. A Pharmaceutical Contract Development & Manufacturing Organization (CDMO) is a specialized corporation that provides comprehensive services to pharmaceutical and biotechnology companies. These services encompass the entire drug development and manufacturing process, from initial product concept to commercial production. CDMOs offer expertise in formulation development, analytical testing, process optimization, and regulatory compliance. They enable clients to outsource various aspects of drug development and production, allowing them to focus on core competencies while benefiting from the CDMO's specialized capabilities and infrastructure.
According to the National Health Commission (NHC), China has over 180 million elderly citizens suffering from chronic diseases, of which 75% have more than one.
Market Dynamics:
Driver:
Rising biopharmaceuticals market
The rising biopharmaceuticals market fuels demand for specialized expertise and infrastructure, driving the expansion of PCDMOs. These organizations offer tailored solutions for drug development, manufacturing, and testing, catering to the unique requirements of biopharmaceuticals. CDMOs streamline processes, reduce costs, and mitigate risks for pharmaceutical companies, fostering innovation and accelerating time-to-market for new therapies. As biopharmaceuticals continue to dominate the market, CDMOs play a pivotal role in supporting their development and commercialization efforts, fueling the growth trajectory of the sector.
Restraint:
Stringent regulatory requirements & compliance standards
Stringent regulatory requirements and compliance standards in CDMOs are essential to ensure product quality, safety, and efficacy. These standards can hamper market growth by increasing operational costs, lengthening development timelines, and creating barriers to entry for smaller companies. Compliance efforts often require substantial resources, leading to higher prices for services and products. Additionally, stringent regulations may deter innovation and limit flexibility in adapting to market demands, thus impeding overall market expansion and competitiveness.
Opportunity:
Growing demand for specialized expertise
As pharmaceutical companies seek to focus on core competencies while leveraging external expertise, CDMOs play a crucial role in providing specialized services such as formulation development, manufacturing, and packaging. This trend is fuelled by the complexities of modern drug development, stringent regulatory requirements, and the need for cost-effective strategies. CDMOs provide a range of services including formulation development, analytical testing, manufacturing, and packaging, allowing pharmaceutical companies to accelerate their product pipelines and bring innovative treatments to market efficiently, thereby propelling market expansion.
Threat:
Pricing pressures
Pricing pressures in CDMOs arise due to increased competition, regulatory changes, and rising costs of raw materials and labor. These pressures often lead to downward pricing trends, squeezing profit margins and hindering investment in innovation and expansion. Consequently, CDMOs may struggle to maintain profitability and may be unable to invest in advanced technologies or infrastructure upgrades. This cycle of constrained investment can impede the development of new drugs and limit the industry's ability to meet evolving healthcare needs.
Covid-19 Impact
The covid-19 pandemic has had mixed impacts on the pharmaceutical contract development & manufacturing organization (CDMO) market. While the demand for certain pharmaceutical products, such as vaccines and treatments, surged, leading to increased outsourcing to CDMOs for manufacturing support, the pandemic also disrupted supply chains and delayed clinical trials and regulatory processes. Overall, the pandemic emphasized the importance of agile and resilient manufacturing capabilities, driving investment in technology and infrastructure to mitigate future disruptions.
The development services segment is expected to be the largest during the forecast period
The development services segment is estimated to have a lucrative growth. A pharmaceutical contract development & manufacturing organization in development services provides comprehensive support from drug discovery to clinical trials. These services include formulation development, analytical method development, stability studies, and regulatory submissions. CDMOs enable pharmaceutical companies to accelerate development timelines, reduce costs, and access specialized expertise, ensuring efficient and compliant progression of drug candidates from concept to clinical evaluation.
The biotechnology companies segment is expected to have the highest CAGR during the forecast period
The biotechnology companies segment is anticipated to witness the highest CAGR growth during the forecast period. CDMOs provide biotechnology companies with specialized services for drug development and production. They offer expertise in areas like formulation, clinical trial support, and large-scale manufacturing. By outsourcing these tasks, biotech firms can focus on innovation and reduce time-to-market for new therapies, benefiting from CDMOs' advanced technologies and regulatory compliance expertise.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period. Rapidly expanding pharmaceutical and biotechnology industries, increasing outsourcing trends from Western companies seeking cost-effective solutions, and the availability of skilled labor at lower costs are key drivers. Additionally, favourable regulatory environments and government initiatives to promote the life sciences sector further boost market growth. With a burgeoning demand for generic drugs and biologics, the Asia Pacific region is becoming a strategic hub for CDMOs offering a wide range of development and manufacturing services.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period. With a focus on innovation, quality, and efficiency, North American CDMOs offer end-to-end solutions spanning drug development, manufacturing, packaging, and supply chain management. The region benefits from a strong regulatory framework, skilled workforce, and advanced infrastructure, attracting both domestic and international clients. Key players constantly invest in R&D and technological advancements to meet evolving industry demands, ensuring competitiveness and sustainability in the market.
Key players in the market
Some of the key players profiled in the Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market include Lonza Group, Catalent Inc., WuXi AppTec, Samsung Biologics, Boehringer Ingelheim BioXcellence, Parexel International, Thermo Fisher Scientific, Siegfried Holding AG, Fujifilm Diosynth Biotechnologies, Recipharm AB, Albany Molecular Research Inc. (AMRI), Piramal Pharma Solutions, Charles River Laboratories, Ajinomoto Bio-Pharma Services, Alcami Corporation, Cambrex Corporation, Hovione, Fareva, Sartorius Stedim BioOutsource, Micron Technologies.
Key Developments:
In June 2023, FUJIFILM Corporation launched a commercial office in Tokyo to provide enhanced sales support and customer service for Contract Development and Manufacturing services for Biologics and Advanced Therapies to Asia-based pharmaceutical and biotechnology companies.
In April 2023, Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, has an agreement with ABL Bio, a pioneering Korean biologics company with a focus on bispecific antibodies for immuno-oncology and neurodegenerative diseases. The collaboration agreement between Lonza and ABL Bio supports the development and manufacturing of ABL Bio’s new bispecific antibody product.
Service Types Covered:
• Development Services
• Manufacturing Services
• Clinical Trial Material (CTM) Production
• Scale-Up Services
• Regulatory Support Services
• Other Service Types
Molecule Types Covered:
• Small Molecule Drugs
• Biologics
• Other Molecule Types
Dosage Forms Covered:
• Solid
• Liquid
• Injectable
• Inhalables
• Other Dosage Forms
Applications Covered:
• Oncology
• Cardiovascular Diseases
• Central Nervous System (CNS) Disorders
• Infectious Diseases
• Metabolic Disorders
• Respiratory Diseases
• Other Applications
End Users Covered:
• Pharmaceutical Companies
• Biotechnology Companies
• Generic Drug Companies
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market, By Service Type
5.1 Introduction
5.2 Development Services
5.2.1 Preformulation Services
5.2.2 Formulation Development
5.2.3 Process Development
5.2.4 Analytical & Quality Control Services
5.3 Manufacturing Services
5.3.1 Active Pharmaceutical Ingredients (API) Manufacturing
5.3.2 Finished Dosage Form Manufacturing
5.3.3 Packaging
5.3.4 Commercial Manufacturing
5.4 Clinical Trial Material (CTM) Production
5.5 Scale-Up Services
5.6 Regulatory Support Services
5.7 Other Service Types
6 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market, By Molecule Type
6.1 Introduction
6.2 Small Molecule Drugs
6.3 Biologics
6.3.1 Monoclonal Antibodies
6.3.2 Vaccines
6.3.3 Recombinant Proteins
6.4 Other Molecule Types
7 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market, By Dosage Form
7.1 Introduction
7.2 Solid
7.3 Liquid
7.4 Injectable
7.5 Inhalables
7.6 Other Dosage Forms
8 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market, By Application
8.1 Introduction
8.2 Oncology
8.3 Cardiovascular Diseases
8.4 Central Nervous System (CNS) Disorders
8.5 Infectious Diseases
8.6 Metabolic Disorders
8.7 Respiratory Diseases
8.8 Other Applications
9 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market, By End User
9.1 Introduction
9.2 Pharmaceutical Companies
9.3 Biotechnology Companies
9.4 Generic Drug Companies
9.5 Other End Users
10 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Lonza Group
12.2 Catalent Inc.
12.3 WuXi AppTec
12.4 Samsung Biologics
12.5 Boehringer Ingelheim BioXcellence
12.6 Parexel International
12.7 Thermo Fisher Scientific
12.8 Siegfried Holding AG
12.9 Fujifilm Diosynth Biotechnologies
12.10 Recipharm AB
12.11 Albany Molecular Research Inc. (AMRI)
12.12 Piramal Pharma Solutions
12.13 Charles River Laboratories
12.14 Ajinomoto Bio-Pharma Services
12.15 Alcami Corporation
12.16 Cambrex Corporation
12.17 Hovione
12.18 Fareva
12.19 Sartorius Stedim BioOutsource
12.20 Micron Technologies
List of Tables
1 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Region (2022-2030) ($MN)
2 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Service Type (2022-2030) ($MN)
3 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Development Services (2022-2030) ($MN)
4 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Preformulation Services (2022-2030) ($MN)
5 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Formulation Development (2022-2030) ($MN)
6 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Process Development (2022-2030) ($MN)
7 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Analytical & Quality Control Services (2022-2030) ($MN)
8 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Manufacturing Services (2022-2030) ($MN)
9 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Active Pharmaceutical Ingredients (API) Manufacturing (2022-2030) ($MN)
10 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Finished Dosage Form Manufacturing (2022-2030) ($MN)
11 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Packaging (2022-2030) ($MN)
12 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Commercial Manufacturing (2022-2030) ($MN)
13 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Clinical Trial Material (CTM) Production (2022-2030) ($MN)
14 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Scale-Up Services (2022-2030) ($MN)
15 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Regulatory Support Services (2022-2030) ($MN)
16 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Other Service Types (2022-2030) ($MN)
17 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Molecule Type (2022-2030) ($MN)
18 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Small Molecule Drugs (2022-2030) ($MN)
19 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Biologics (2022-2030) ($MN)
20 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Monoclonal Antibodies (2022-2030) ($MN)
21 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Vaccines (2022-2030) ($MN)
22 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Recombinant Proteins (2022-2030) ($MN)
23 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Other Molecule Types (2022-2030) ($MN)
24 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Dosage Form (2022-2030) ($MN)
25 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Solid (2022-2030) ($MN)
26 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Liquid (2022-2030) ($MN)
27 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Injectable (2022-2030) ($MN)
28 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Inhalables (2022-2030) ($MN)
29 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Other Dosage Forms (2022-2030) ($MN)
30 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Application (2022-2030) ($MN)
31 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Oncology (2022-2030) ($MN)
32 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Cardiovascular Diseases (2022-2030) ($MN)
33 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Central Nervous System (CNS) Disorders (2022-2030) ($MN)
34 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Infectious Diseases (2022-2030) ($MN)
35 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Metabolic Disorders (2022-2030) ($MN)
36 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Respiratory Diseases (2022-2030) ($MN)
37 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Other Applications (2022-2030) ($MN)
38 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By End User (2022-2030) ($MN)
39 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Pharmaceutical Companies (2022-2030) ($MN)
40 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Biotechnology Companies (2022-2030) ($MN)
41 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Generic Drug Companies (2022-2030) ($MN)
42 Global Pharmaceutical Contract Development & Manufacturing Organization (CDMO) Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
